Ms. Guannan Ma | Microbial Cell Biology | Best Researcher Award

Ms. Guannan Ma , Zhejiang Key Laboratory of Digital Technology in Medical Diagnostics , China

Guannan Ma is a seasoned biomedical researcher and medical manager based in Beijing, China, with over a decade of experience in molecular biology, genomics, and clinical research. He currently works at DIAN Gene Co., Ltd., where he leads clinical research projects, scientific writing, and patent development. With a strong academic foundation and a passion for translational medicine, he bridges laboratory research and real-world applications in diagnostics and therapeutics. His background includes extensive collaboration with national R&D initiatives and hospital systems, reflecting his ability to manage interdisciplinary projects and mentor junior scientists. Guannan is the co-author of over 15 peer-reviewed SCI papers and multiple patents in the fields of gene editing, DNA data storage, and cancer biology. Fluent in both English and Chinese, he is also certified in Good Clinical Practice (GCP), ensuring ethical and high-quality research standards. His contributions mark him as a strong contender for the Best Researcher Award.

Publication Profile: 

Orcid

✅ Strengths for the Award:

1. 📚 Extensive Publication Record

   • Over 15 SCI-indexed publications in top-tier journals such as Redox Biology, Advanced Science, and Genomics Proteomics Bioinformatics with a cumulative impact factor exceeding 60.

2. 🔬 Interdisciplinary Research Expertise

   • Proven proficiency in multi-omics, CRISPR, genetic engineering, clinical research, and data analysis. His work spans microbiology, genomics, and translational medicine.

3. 💡 Innovation & Intellectual Property

   • Multiple patents, including breakthrough innovations in DNA storage and cancer biomarker regulation, highlighting strong translational value and originality.

4. 🌍 International and National Project Leadership

   • Key contributor to national R&D projects (e.g., DNA storage, microbiota gene adaptation) and cross-institutional collaborations.

5. 📈 Clinical Impact & GCP Certification

   • Designs and executes clinical research supporting product development, demonstrating clear real-world applications.

6. 👥 Mentorship and Team Leadership

   • Has supervised students, trained staff, and coordinated multicenter studies—showing strong leadership and collaborative aptitude.

🛠 Areas for Improvement:

1. 🌐 Broader International Exposure

   • While Guannan has studied abroad, further global collaborations or fellowships (e.g., Horizon Europe, NIH, or WHO research programs) could enhance his international recognition.

2. 📣 Science Communication & Outreach

   • Increasing science communication efforts (e.g., webinars, social media, TEDx talks) would help raise visibility of his research beyond academic audiences.

3. 🔄 Continuous Skill Upgrading

   • Pursuing cutting-edge training in AI-based bioinformatics or clinical trial informatics could keep his expertise aligned with rapidly evolving biomedical tools.

🎓 Education:

Guannan Ma holds a Master of Science degree in Marine Science and Engineering from Tianjin University of Science and Technology (2012–2015), complemented by a year as a visiting Master’s student at Ghent University, Belgium (2014–2015). This dual exposure to domestic and international academic environments provided him with a robust interdisciplinary foundation. At Tianjin University, he developed a solid grasp of molecular biology, environmental genomics, and research methodologies, while his time at Ghent University enriched his perspective on global scientific standards and collaborative innovation. These academic experiences not only honed his technical expertise but also shaped his strong commitment to academic excellence and scientific rigor. His education played a crucial role in shaping his current research path, which integrates cutting-edge biotechnology, clinical research, and bioinformatics, and laid the groundwork for his involvement in high-impact national and international scientific projects.

💼 Experience:

Guannan Ma brings 10 years of diverse research and clinical project experience. Currently, as Medical Manager at DIAN Gene Co., Ltd. (since June 2022), he leads clinical study design, publication development, academic training, and patent filing. Prior to this, he spent over seven years (2015–2022) at the Beijing Institute of Genomics, Chinese Academy of Sciences, where he contributed to national research grants, supervised students, and mastered technologies like CRISPR-Cas9, ELISA, and mouse modeling. His work also included managing large-scale omics data and integrating microbiome, genetic, and metabolomic research. Across both roles, Guannan has demonstrated exceptional project leadership, technical fluency, and collaborative engagement across multi-disciplinary teams. His work has resulted in 15 high-impact SCI publications and multiple innovations in molecular diagnostics, microbial resistance, and gene therapy. With deep roots in both academia and industry, he exemplifies a rare blend of scientific depth, clinical insight, and leadership potential.

🔬 Research Focus:

Guannan Ma’s research focuses on the intersection of molecular biology, genomics, microbiome science, and clinical translation. His core areas include multi-omics data integration (genomics, transcriptomics, and metabolomics), gene editing (CRISPR-Cas9), and the development of diagnostic tools using advanced sequencing technologies such as Nanopore. He is particularly interested in antimicrobial resistance, host-pathogen interactions, and precision medicine strategies for diseases like cancer and infectious disorders. His recent contributions at DIAN Gene Co., Ltd. include initiating and leading clinical trials to support product indications, conducting systematic literature reviews, and ensuring the scientific integrity of marketing content. Guannan’s patent portfolio spans DNA data storage systems and microRNA-mediated cancer pathways, reflecting his commitment to high-impact innovation. He also supports scientific communication through English/Chinese academic writing and staff training. His work bridges scientific discovery and clinical application, driving forward patient-centered solutions rooted in cutting-edge genomics and biotechnology.

📚 Publications Top Notes:

1. 🧫 Redox imbalance in disease: Role of redox biology in clinical research – Redox Biology, 2024

2. 👶 Exploring biomarkers in pediatric diagnostics – Frontiers in Pediatrics, 2025

3. 💊 Pharmacogenomics in personalized medicine – Pharmacogenomics and Personalized Medicine, 2024

4. 🧪 Nanomaterials and biomedical advancements – Advanced Science, 2024

5. 🦠 Candida auris strain characterization from bloodstream infections – Clinics, 2024

6. 🧬 Probiotics in elderly pneumonia patients: Gut flora insights – Medicine, 2023

7. 🔍 Digital twin systems for high-precision optical engineering – Preprints.org, 2023

8. 🎵 Music therapy effectiveness in ASD children: Meta-analysis – Frontiers in Psychiatry, 2022

9. 💾 DNA data storage: Encoding-decoding techniques overview – CCF Trans. on High Performance Computing, 2022

10. 🧫 Genomic epidemiology of resistant Klebsiella pneumoniae strains – Genomics Proteomics Bioinformatics, 2022

🧾 Conclusion:

Guannan Ma is an exceptionally strong candidate for the Best Researcher Award. His balanced combination of scientific depth, innovation, and applied clinical relevance stands out. With a publication history that demonstrates both quality and breadth, contributions to national innovation priorities, and a proven track record of mentorship and teamwork, he embodies the qualities of a high-impact, future-forward researcher. By extending his global footprint and amplifying public engagement, Guannan Ma has the potential to become a key thought leader in life sciences and medical biotechnology.